A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia

NCT02780115 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Presbyopia

Interventions

DRUG: AGN-199201 ophthalmic solution
DRUG: AGN-190584 ophthalmic solution
DRUG: AGN-199201 Vehicle
DRUG: AGN-190584 Vehicle

Sponsor

Allergan